Answers are grounded in this paper and cite their sources.
Treatment for osteosarcoma, a paediatric bone cancer with no therapeutic advances in over three decades, is limited by a lack of targeted therapies. Osteosarcoma frequently metastasises to the lungs, and only 20% of patients survive 5 years after the diagnosis of metastatic disease. We found that WNT5B is the most abundant WNT expressed in osteosarcoma tumours and its expression correlates with metastasis, histologic subtype and reduced survival.
No takes yet. Share an insight, caveat, or question.
Perkins et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: